Search
for
Sort by
Research 901–930 of 1000+
- Mesenchymal stem/stromal cell therapy in atopic dermatitis and chronic urticaria: immunological and clinical viewpoints
- Chikungunya virus infection in the skin: histopathology and cutaneous immunological response
- Extracellular vesicles as precision therapeutics for psychiatric conditions: targeting interactions among neuronal, glial, and immune networks
- The Role of the Microbiome in the Resolution of Infection-Induced Inflammation
- Advances in Extraction Technologies of Silybum marianum L. and Its Role in Protecting Against Skin Damage
- JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology
- Mechanistic Insights on Dyspepsia Modulation by Salvia rosmarinus Through Network Pharmacology, Molecular Docking, and Molecular Dynamics
- Mir-574-3p and Mir-125a-5p in Adipose Derived Mesenchymal Stem Cell Exosomes Synergistically Target TGF-β1/Smad2 Signaling Pathway for the Treatment of Androgenic Alopecia
- Recent approaches of antibody therapeutics in androgenetic alopecia
- Alopecia Areata in Latin America: Where are We and Where are We Going?
- The Spectrum of Cutaneous Manifestations in Lupus Erythematosus: A Comprehensive Review
- Prevalence of Metabolic Syndrome among Apparently Healthy Adult Population in Pakistan: A Systematic Review and Meta-Analysis
- International Consensus Guidelines on the Safe and Evidence-Based Practice of Mesotherapy: A Multidisciplinary Statement
- Genetically determined metabolites in allergic conjunctivitis: A Mendelian randomization study
- Scarring Alopecias: Pathology and an Update on Digital Developments
- An examination of Alzheimer’s disease and white matter from 1981 to 2023: a Bibliometric and visual analysis
- Data-driven strategies for drug repurposing: insights, recommendations, and case studies
- Comparative study of male and female human hair: A microscopic analysis.
- Author guidelines in medical journals: Essential rules and rationale
- CGF therapy: bridging androgenetic alopecia observations to psoriasis treatment via IL-17 pathway
- Micropigmentation
- COVID-19 Symptoms: Longitudinal Evolution and Persistence in Outpatient Settings
- A preliminary observation: Male pattern hair loss among hospitalized COVID‐19 patients in Spain – A potential clue to the role of androgens in COVID‐19 severity
- Androgenetic alopecia present in the majority of patients hospitalized with COVID-19: The “Gabrin sign”
- COVID-19 vaccines while pregnant or breastfeeding
- COVID‐19 with dermatologic manifestations and implications: An unfolding conundrum
- Telogen effluvium: a sequela of COVID‐19
- What does androgenetic alopecia have to do with COVID‐19? An insight into a potential new therapy
- Telogen effluvium associated with COVID‐19 infection
- Time of onset and duration of post-COVID-19 acute telogen effluvium